Envista Holdings Price Target Cut to $17.00/Share From $19.00 by Baird
Envista Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), Solid Biosciences (SLDB) and Lexeo Therapeutics, Inc. (LXEO)
Envista Holdings: Hold Rating Maintained Amidst Executive Appointments and Uncertain Impact on Financial Performance
Analysts' Top Healthcare Picks: Accolade (ACCD), Envista Holdings (NVST)
Envista Holdings Analyst Ratings
Analysts' Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Johnson & Johnson (JNJ) and CVS Health (CVS)
Morgan Stanley Remains a Hold on Envista Holdings (NVST)
Envista Holdings Analyst Ratings
Envista Holdings Analyst Ratings
Envista Holdings: A Period of Transition With Cautious Optimism Under New Leadership
Analysts Offer Insights on Healthcare Companies: Werewolf Therapeutics (HOWL), Eli Lilly & Co (LLY) and Envista Holdings (NVST)
Envista Holdings: A Cautious Hold Amidst Turnaround Efforts and Management Transition
Envista Holdings Analyst Ratings
Baird Maintains Neutral on Envista Holdings, Lowers Price Target to $19
Analysts Offer Insights on Healthcare Companies: NeoGenomics (NEO) and Envista Holdings (NVST)
Envista Holdings Analyst Ratings
Envista Holdings Analyst Ratings
Envista Holdings: Navigating Leadership Changes and Long-Term Turnaround Challenges
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), Nyxoah (NYXH) and Zoetis (ZTS)
No Data